Kiniksa Pharmaceuticals International Plc (KNSA)
94.59
+1.30
(+1.39%)
USD |
NASDAQ |
Nov 04, 13:21
Kiniksa Pharmaceuticals International Price : 94.59 for Nov. 4, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 03, 2026 | 90.44 | 94.84 | 90.44 | 93.29 | 1.022M |
| Nov 02, 2026 | 92.83 | 94.17 | 90.56 | 90.80 | 998882.0 |
| Oct 30, 2026 | 97.40 | 98.48 | 91.25 | 92.24 | 1.320M |
| Oct 29, 2026 | 95.00 | 98.36 | 94.40 | 97.56 | 1.380M |
| Oct 28, 2026 | 87.88 | 95.28 | 87.54 | 95.18 | 1.707M |
| Oct 27, 2026 | 85.00 | 90.80 | 82.26 | 89.20 | 2.321M |
| Oct 26, 2026 | 76.00 | 76.48 | 70.67 | 72.98 | 1.434M |
| Oct 23, 2026 | 80.16 | 80.22 | 76.58 | 76.73 | 576558.0 |
| Oct 22, 2026 | 79.32 | 81.30 | 78.39 | 80.79 | 429711.0 |
| Oct 21, 2026 | 83.41 | 84.06 | 78.74 | 79.70 | 838634.0 |
| Oct 20, 2026 | 80.25 | 83.78 | 79.88 | 83.17 | 1.238M |
| Oct 19, 2026 | 78.78 | 80.61 | 78.36 | 79.48 | 602145.0 |
| Oct 16, 2026 | 79.94 | 80.34 | 76.88 | 78.59 | 525188.0 |
| Oct 15, 2026 | 79.85 | 82.98 | 79.62 | 79.94 | 1.485M |
| Oct 14, 2026 | 78.12 | 79.96 | 77.70 | 78.84 | 576559.0 |
| Oct 13, 2026 | 79.21 | 80.00 | 78.45 | 78.53 | 575787.0 |
| Oct 12, 2026 | 80.00 | 80.99 | 78.82 | 79.24 | 340940.0 |
| Oct 09, 2026 | 78.24 | 80.50 | 78.03 | 79.78 | 430280.0 |
| Oct 08, 2026 | 77.18 | 78.83 | 75.44 | 78.75 | 411567.0 |
| Oct 07, 2026 | 76.18 | 79.22 | 74.70 | 77.96 | 381046.0 |
| Oct 06, 2026 | 76.00 | 77.32 | 73.84 | 77.09 | 378744.0 |
| Oct 05, 2026 | 75.97 | 76.79 | 75.28 | 76.31 | 391512.0 |
| Oct 02, 2026 | 75.58 | 76.22 | 74.56 | 75.79 | 376308.0 |
| Oct 01, 2026 | 73.87 | 76.11 | 73.14 | 75.22 | 878563.0 |
| Sep 30, 2026 | 76.55 | 76.55 | 73.76 | 74.61 | 650611.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Autolus Therapeutics Plc | 1.395 |
| Scancell Holdings Plc | 1.18 |
| OptiBiotix Health Plc | 0.11 |
| Adaptimmune Therapeutics Plc | 0.025 |
| Oxford Biomedica Plc | 7.21 |
Price Related Metrics
| PE Ratio | 72.17 |
| PS Ratio | 8.307 |
| PEG Ratio | 0.3752 |
| Price to Book Value | 10.45 |
| Price to Free Cash Flow | 39.85 |
| Earnings Yield | 1.39% |
| Market Cap | 7.424B |
| PEGY Ratio | 0.3752 |
| Operating PE Ratio | 60.23 |
| Normalized PE Ratio | 72.17 |